Pharma Pulse 3/29/24: Super Micro’s AI Boom Carries a Big Price Tag, Leveraging Digital Tools to Optimize Manufacturing & more

Leveraging Digital Tools to Optimize Manufacturing Processes

Barry Heavey, Life Sciences Supply Chain Lead, Accenture, discusses how companies can leverage digital tools like artificial intelligence and machine learning to optimize manufacturing processes and ensure efficient production.

What States are Doing to Regulate Pharmacy Benefit Managers

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers found that state-level PBM reform focused on more transparent drug pricing, better patient access to prescription drugs, and more stringent auditing and reporting requirements.

Super Micro’s AI Boom Carries a Big Price Tag

Maker of Nvidia-based AI servers has a hot hand, but high-cost business model leaves stock looking overheated.

FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration has approved the supplemental new drug application (sNDA) for Vemlidy®(tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B virus (HBV) infection in pediatric patients six years of age and older and weighing at least 25 kg with compensated liver disease.

Travis Meeks on LinkedIn:

By linking people-based data and insights to NPI, healthcare marketers can unlock an in-depth view of HCPs as unique individuals in order to better target and communicate with them. This not only improves HCP marketing engagement but also has the potential to help providers better serve patients.
Learn more in this article from AnalyticsIQ's Christine (Boley) Lee via Pharmaceutical Executive.
#NPI #HCPEngagement #HealthcareMarketing

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs